US · SFD · PACKAGED FOODS
Smithfield Foods, Inc. (SFD) intrinsic value and stock valuation
$19.13as of 2026-11-21 · Mkt cap 9.93B
Data updated · price as of 2026-11-21
- P/E
- Pro
- P/B
- Pro
- P/S
- Pro
Price history
Price charts, the InvestorsCraft value line, and the fair-value band are Pro features.
Smithfield Foods, Inc. DCF and intrinsic value
InvestorsCraft values SFD with the Chepakovich two-stage DCF model — currently rated strongly undervalued. How the model works · Run your own DCF prefilled from SFD’s statements →
Smithfield Foods, Inc. Graham Number
Graham Number: $31.95d — the price is at or below the Graham Number. Formula √(22.5 × EPS × BVPS) using the latest diluted EPS and book value per share. Guide · Calculator →
How the business is doing
Fiscal 2006–2025, USD
Is it expensive?
Each multiple against its own 15-year range, or against peers where no history is available
Peers
Same-industry companies, ranked by market cap
- New Oriental Education & Technology Group Inc. (EDU) $51.03
- Sprouts Farmers Market, Inc. (SFM) $48.81
- Molson Coors Beverage Company (TAP) $39.23
- Lamb Weston Holdings, Inc. (LW) $51.70
- Conagra Brands, Inc. (CAG) $14.92
- Campbell Soup Company (CPB) $23.78
- Ingredion Incorporated (INGR) $89.19
- Pilgrim's Pride Corporation (PPC) $28.60
Peer comparison
The peer comparison table is shown only to users with a Pro subscription.
Financials
Statements by fiscal year
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $15.5B | $14.1B | $14.6B | $16.2B | $15B |
| Operating income | $1.29B | $1.12B | -$-56M | $1.12B | $521M |
| Net income | $987M | $953M | $17M | $870M | $472M |
| EPSd | $2.51M | $2.51M | $43.2K | $2.29M | $1.2M |
| Operating cash flow | $1.06B | $1.14B | $1.03B | $517M | $786M |
| Capital expenditure | -$-341M | -$-350M | -$-401M | -$-338M | -$-213M |
| Free cash flow | $718M | $787M | $633M | $179M | $573M |
| Total assets | $12.2B | $11.1B | $13.3B | $13.8B | — |
| Total debt | $2.4B | $2.36B | $2.46B | $2.47B | — |
| Net debt | $857M | $1.42B | $1.78B | $1.92B | — |
| Total equity | $7.07B | $6.06B | $7.49B | $7.57B | — |
| Cash and short-term investments | $1.54B | $943M | $687M | $547M | — |
Income statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $15.5B | $14.1B | $14.6B | $16.2B | $15B |
| Cost of revenue | $13.4B | $12.2B | $13.8B | $14.7B | $13.4B |
| Gross profit | $2.09B | $1.9B | $889M | $1.5B | $1.57B |
| Research and development expenses | $0.00 | $0.00 | $0.00 | $157M | $0.00 |
| Selling, general and administrative expenses | $849M | $840M | $1.05B | $807M | $1.1B |
| Other expenses | -$-52M | -$-60M | -$-105M | -$-586M | -$-44M |
| Operating expenses | $797M | $780M | $945M | $378M | $1.05B |
| Cost and expenses | $14.2B | $13B | $14.7B | $15.1B | $14.5B |
| Interest income | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Interest expense | $41M | $66M | $76M | $87M | $93M |
| Depreciation and amortization | $332M | $339M | $427M | $440M | $331M |
| Ebitda | $1.64B | $1.47B | $374M | $1.57B | $882M |
| Operating income | $1.29B | $1.12B | -$-56M | $1.12B | $521M |
| Total other income/expenses, net | -$-10M | -$-49M | -$-118M | -$-75M | -$-35M |
| Income before tax | $1.28B | $1.07B | -$-174M | $1.04B | $486M |
| Income tax expense | $283M | $271M | -$-41M | $231M | $97M |
| Net income | $987M | $953M | $17M | $870M | $472M |
| Weighted average shares outstanding | $392M | $463.8M | $393.1M | $414.3M | $393.1M |
| Weighted average diluted shares outstanding | $392.7M | $380.1M | $393.1M | $380.1M | $393.1M |
Balance sheet
| 2025 | 2024 | 2023 | 2022 | 2016 | |
|---|---|---|---|---|---|
| Cash and short-term investments | $1.54B | $943M | $687M | $547M | $704.9M |
| Net receivables | $1.02B | $558M | $577M | $756M | $760M |
| Inventory | $2.33B | $2.41B | $2.54B | $2.93B | $2.1B |
| Total current assets | $5.17B | $4.2B | $4.92B | $5.54B | $3.74B |
| Property, plant and equipment, net | $3.61B | $3.51B | $3.73B | $3.79B | $2.87B |
| Goodwill and intangible assets | $2.88B | $2.88B | $2.9B | $2.9B | $2.99B |
| Long-term investments | $209M | $202M | $191M | $224M | $142.5M |
| Total non-current assets | $7.01B | $6.85B | $8.4B | $8.31B | $6.15B |
| Total assets | $12.2B | $11.1B | $13.3B | $13.8B | $9.89B |
| Accounts payable | $856M | $777M | $789M | $1.02B | $686.1M |
| Short-term debt | $74M | $73M | $132M | $81M | $30.3M |
| Deferred revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total current liabilities | $1.74B | $1.71B | $2.45B | $2.59B | $1.54B |
| Long-term debt | $2.32B | $2.29B | $2.33B | $2.39B | $2.26B |
| Deferred revenue, non-current | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total non-current liabilities | $3.37B | $3.29B | $3.38B | $3.69B | $3.47B |
| Capital lease obligations | $393M | $358M | $388M | $431M | $0.00 |
| Total liabilities | $5.11B | $5B | $5.83B | $6.28B | $5.02B |
| Common stock | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Retained earnings | $3.78B | $3.18B | $3.59B | $3.89B | $1.01B |
| Accumulated other comprehensive income (loss) | -$-314M | -$-452M | -$-500M | -$-708M | -$-377.7M |
| Total equity | $7.07B | $6.06B | $7.49B | $7.57B | $4.87B |
| Total investments | $209M | $202M | $191M | $224M | $142.5M |
| Total debt | $2.4B | $2.36B | $2.46B | $2.47B | $2.29B |
| Net debt | $857M | $1.42B | $1.78B | $1.92B | $1.58B |
Cash flow statement
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net income | $987M | $798M | -$-139M | $811M | $388M |
| Depreciation and amortization | $332M | $339M | $427M | $440M | $331M |
| Stock-based compensation | $9M | $0.00 | $0.00 | $0.00 | $0.00 |
| Change in working capital | -$-339M | -$-285M | $551M | -$-308M | $30M |
| Accounts receivable | -$-470M | -$-6M | $157M | -$-33M | -$-2M |
| Inventory | $118M | $138M | $469M | -$-307M | -$-184M |
| Accounts payable | $65M | -$-19M | -$-215M | $121M | $188M |
| Net cash provided by operating activities | $1.06B | $1.14B | $1.03B | $517M | $786M |
| Investments in property, plant and equipment | -$-341M | -$-350M | -$-401M | -$-338M | -$-213M |
| Acquisitions, net | $0.00 | -$-13M | $232M | $584M | $5M |
| Net cash used for investing activities | -$-309M | -$-469M | -$-322M | $193M | -$-330M |
| Common stock issued | $236M | $0.00 | $0.00 | $0.00 | $0.00 |
| Common stock repurchased | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Dividends paid | -$-396M | -$-288M | -$-323M | -$-496M | -$-192M |
| Net cash used for financing activities | -$-164M | -$-464M | -$-533M | -$-477M | -$-337M |
| Net change in cash | $596M | $192M | $140M | $245M | -$-704.9M |
| Cash at end of period | $1.54B | $943M | $687M | $570M | $325M |
| Operating cash flow | $1.06B | $1.14B | $1.03B | $517M | $786M |
| Capital expenditure | -$-341M | -$-350M | -$-401M | -$-338M | -$-213M |
| Free cash flow | $718M | $787M | $633M | $179M | $573M |
Line items
Line items
Line items
About Smithfield Foods, Inc.
Smithfield Foods, Inc., together with its subsidiaries, produces various packaged meats and fresh pork products in the United States and internationally. It operates through Packaged Meats, Fresh Pork, Hog Production, and Other segments. The Packaged Meats segment processes fresh meat into various packaged meats products, including bacon, sausage, hot dogs, deli and lunch meats, dry sausage products, ham products, ready-to-eat products, and prepared foods to retail and foodservice customers. This segment markets its packaged meat products under the Smithfield, Eckrich, Nathan’s Famous, Farmland, Armour, Farmer John, Kretschmar, Krakus, John Morrell, Cook’s, Gwaltney, Carando, Margherita, Curly’s and Smithfield Culinary, as well as under private labels. The Fresh Pork segment processes live hogs into a variety of primal, sub-primal, and offal products, such as bellies, butts, hams, loins, trimmings, picnics, and ribs. This segment sells its fresh pork products to retail, foodservice and industrial customers, as well as to export markets, including China, Mexico, Japan, South Korea, and Canada. The Hog Production segment produces and raises its hogs on various company-owned farms and farms that are owned and operated by contract farmers. This segment also sells livestock feed and grains; and provides transportation and other ancillary services. The Other segment engages in the bioscience operations uses raw materials from hogs that process to manufacture heparin products, including an active pharmaceutical ingredient that mitigates the risk of blood clots; and produces fresh pork products in Mexico. The company was founded in 1936 and is headquartered in Smithfield, Virginia. Smithfield Foods, Inc. is a subsidiary of SFDS UK Holdings Limited.
- CEO
- Charles Shane Smith
- Employees
- 32K
- Beta
- -0.50
Explore
Frequently asked questions
What is the intrinsic value of Smithfield Foods, Inc. (SFD)?
Smithfield Foods, Inc. (SFD) is currently strongly undervalued based on the InvestorsCraft IC model — IC value is more than 50% above the price. The exact intrinsic value is available to Pro subscribers. How the IC value is calculated.
Is SFD undervalued?
SFD trades at a price of $19.13 (Nov 21, 2026): strongly undervalued — IC value is more than 50% above the price.
How is the intrinsic value calculated?
InvestorsCraft estimates intrinsic value with four methods: the Chepakovich valuation model (IC), an AI-assisted estimate, the Graham-Dodd formula, and the Graham Formula. How the IC value is calculated.
How often is this page updated?
Prices are refreshed each trading day; valuation inputs update when new financial statements are processed. This page was last updated Nov 21, 2026.
Disclaimer: Information on this page is provided for educational purposes only and does not constitute investment advice. Figures marked d are derived from the figures shown — for example upside = IC ÷ price − 1, CAGR over the last five fiscal years, and range bounds are 15-year or peer minimum and maximum.